PeptidePedia The community reference

Syringe dead space (revision 9)

Old revision·15:56, 23 Sep 2025·MissedDoseMik

This is an old revision of this page, as it stood at 15:56, 23 Sep 2025, saved by MissedDoseMik with the summary British spelling per PP:MOS. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Syringe dead space
Also known asResidual volume; hold-up volume; wastage volume
LocationNeedle hub, needle lumen, plunger-tip recess
Reported magnitude0.002–0.100 mL depending on configuration
Dominant contributorHub cavity, not the needle lumen
Topic infobox · conventions

Syringe dead space is the volume of liquid that remains inside a syringe and its needle after the plunger has been fully depressed. It occupies the cavity of the needle hub, the lumen of the needle itself and any recess in the face of the plunger tip, and it is not delivered to the injection site.[1]

The quantity matters for two distinct reasons that are frequently conflated. First, the retained liquid is discarded with the device, so each injection consumes the nominal dose plus the dead-space volume; over the life of a reconstituted vial this reduces the number of doses obtainable. Second, if the dead space is occupied by air rather than liquid at the moment the plunger position is read against the graduations, and that air is subsequently expelled, the volume actually delivered is smaller than the volume indicated. The first effect is a wastage problem and does not alter the delivered dose; the second is a dose error and can be large.[2]

Magnitudes vary across almost two orders of magnitude between device types. A 1 mL insulin syringe with a permanently attached fine needle has a dead space of a few microlitres, because the plunger tip enters the needle hub and displaces almost all of it. A general-purpose syringe with a detachable needle on a Luer fitting retains of the order of 70–100 µL, most of it in the hub rather than in the needle.[1][3]

Anatomy and terminology

[edit]

A hypodermic syringe delivers liquid by advancing a plunger through a graduated barrel. The graduations relate to the position of the plunger tip, so the volume expelled is the barrel volume swept between the starting and finishing plunger positions. Any volume distal to the plunger tip at full depression is outside that swept volume and is retained.

Three cavities contribute:

  • the hub, the conical or cylindrical space between the end of the barrel and the proximal end of the needle cannula, which in a Luer fitting is a substantial void;
  • the needle lumen, the bore of the cannula itself;
  • the plunger-tip recess, any concavity in the elastomeric or moulded tip that is not filled by the barrel end when fully advanced.

Terminology in the literature is inconsistent. Dead space, dead volume, residual volume and hold-up volume are all used for the same quantity, and residual volume is also used in a different sense for liquid left in the source container after withdrawal. The two are separate: the liquid left in a vial because the needle cannot reach it, or because the vial geometry traps it, is a container property and is discussed at underfilling and at vial. This article uses dead space for the syringe-and-needle quantity only.[4]

The distinction between high dead-space and low dead-space devices entered the literature through injecting-drug-use epidemiology, where the retained volume determines how much blood a shared syringe can transfer. Low-dead-space designs achieve their reduction either by moulding the needle permanently into a plunger-penetrable hub, or by fitting a plastic insert into an otherwise standard Luer hub so that the plunger tip advances into it.[3]

Measured and computed magnitudes

[edit]

Published measurements are made gravimetrically: the assembled device is filled, fully discharged, and the retained mass determined by weighing, with density assumed. Values below are representative of those reported in the injection-equipment literature and vary between manufacturers of nominally equivalent devices.[1][3]

Dead space by device configuration
!ConfigurationDead spaceDominant cavity
1 mL insulin syringe, permanently attached 29–31G needle0.002–0.006 mLPlunger-tip recess
1 mL syringe, Luer slip, 25G × 16 mm detachable needle≈0.070 mLHub
3 mL syringe, Luer lock, 21G × 25 mm detachable needle0.080–0.100 mLHub
Luer hub with no needle fitted≈0.060 mLHub
Low-dead-space insert needle on a Luer hub≈0.010 mLResidual hub void

The consistent finding is that the hub dominates. This is counter-intuitive, because the needle is the visibly narrow and visibly long component, but the arithmetic is unambiguous once the lumen volume is computed from tubing dimensions.[5]

References

  1. ^ a b c Zule WA, Bobashev G. "High dead-space syringes and the risk of HIV and HCV infection among injecting drug users." Drug and Alcohol Dependence 100(3):204–213 (2009).
  2. ^ Strauss K, van Zundert A, Frid A, Costigliola V. "Pandemic influenza preparedness: the critical role of the syringe." Vaccine 24(24):4874–4882 (2006).
  3. ^ a b c Zule WA, Cross HE, Stover J, Pretorius C. "Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries." International Journal of Drug Policy 24(1):1–7 (2013).
  4. ^ ISO 7886-1:2017, Sterile hypodermic syringes for single use — Part 1: Syringes for manual use. International Organization for Standardization.
  5. ^ ISO 9626:2016, Stainless steel needle tubing for the manufacture of medical devices — Requirements and test methods. International Organization for Standardization.